The use of second generation FLT3 inhibitors for AML - 101793

Spotlight
Video

The use of second generation FLT3 inhibitors for AML

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: As treatment advancements are made, the number of people who cannot be treated effectively is reduced. In this interview, Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy, discusses the exciting use of second generation inhibitors of FLT3 for acute myeloid leukemia. This interview was recorded at the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH).
Shared By : VJHemOnc
Posted on : 11/22/17
Added : 11 months ago